Shaanxi Panlong Pharmaceutical Group Co., Ltd. (SZSE: 002864)
Health Care · Pharmaceuticals · CN
CN¥21.61
-3.53% today · -9.3% 1Y
Shaanxi Panlong Pharmaceutical Group Co., Ltd. (SZSE: 002864) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $442.59M and employs 926 people.
Over the last twelve months the share price has lost 9.3%, trading between 19.00 and 32.98.
Tweenvest scores Shaanxi Panlong Pharmaceutical Group Co., Ltd. across four factors: quality 74/100, value 51/100, growth 41/100, dividend 73/100. Its strongest factor is quality.
002864 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $442.59M
- Revenue (TTM)
- $161.39M
- P/E
- 33.83
- EPS
- 0.64
- Dividend yield
- 1.25%
- Beta (5Y)
- -0.27
- 52-week high
- CN¥32.98
- 52-week low
- CN¥19.00
- Avg volume (3M)
- —
- Shares outstanding
- 137.68M
- Employees
- 926
- Next earnings
- —
About Shaanxi Panlong Pharmaceutical Group Co., Ltd.
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd is a pharmaceutical enterprise based in China, comprehensively engaging in the research, development, production, and sale of pharmaceutical products. Furthermore, the company undertakes the GAP-compliant cultivation of medicinal raw materials. Its diverse product portfolio spans numerous therapeutic categories, including orthopedic, cardio-cerebrovascular, digestive, nutritional supplement, respiratory, Traditional Chinese Anti-Inflammatory, pediatric, gynecological, hepatobiliary, and various specialty drugs. Established in 1997, the company maintains its headquarters in Xi'an, China.
- ISIN
- CNE1000032C9
- Founded
- 1997
- Listed since
- Nov 16, 2017
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,240.63 | -1.18% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.52 | +0.47% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.55 | -1.31% |
| Roche Holding AGSWX: ROP | $373.91B | CHF369.10 | -1.73% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £120.32 | -1.70% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $27.93 | -0.50% |
Figures last refreshed Aug 18, 2026.